BioCentury
ARTICLE | Clinical News

OMS201: Phase I data

January 5, 2009 8:00 AM UTC

In a double-blind, vehicle-controlled Phase I trial in patients undergoing endoscopic removal of urinary stones, OMS201 did not produce serious adverse events. Also, plasma levels of the active ingred...